How hepatitis E can affect the brain and nerves, studied in gerbils

A gerbil model to delineate the mechanism of hepatitis E virus extrahepatic pathogenesis

NIH-funded research Virginia Polytechnic Inst and St Univ · NIH-11228398

Researchers will use gerbils to learn how hepatitis E virus can infect brain cells and cause nerve and brain damage.

Quick facts

Grant typeR37 grant
Study typeNIH-funded research
Funding institutionVirginia Polytechnic Inst and St Univ NIH-funded
Lab location1 site (Blacksburg, United States)
Project IDNIH-11228398 on NIH RePORTER

What this research studies

This project uses gerbils that are susceptible to several types of hepatitis E virus to model how the virus reaches and harms the brain and nerves. Scientists will look at infection of cells in the neurovascular unit (brain endothelial cells, microglia, and astrocytes), measure inflammatory signals like IL-18 and TNF-α, and study cell death pathways such as pyroptosis that may drive neurological injury. The team builds on prior findings in pigs and cell models and will correlate virus presence with tissue damage and inflammation in the gerbil brain. Results aim to show the specific steps by which hepatitis E causes extrahepatic (outside the liver) neurological problems.

Who could benefit from this research

Good fit: People who recently had hepatitis E infection or who developed unexplained neurological symptoms after hepatitis E would be the most relevant candidates for future related clinical work.

Not a fit: People without hepatitis E infection or whose neurological symptoms are known to come from another cause are unlikely to benefit from this research directly.

Why it matters

Potential benefit: If successful, this work could explain why hepatitis E sometimes causes neurological complications and point to targets to prevent or treat those problems.

How similar studies have performed: Previous studies in infected pigs and lab-grown brain cells have shown HEV can reach and inflame brain tissue, but using gerbils to map the exact damage pathways is a new approach.

Where this research is happening

Blacksburg, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.